ARROWHEAD PHARMACEUTICALS, INC. (ARWR) Stock Profile — Insider Trades & Financials

Revenue$264.0M

Net Income$30.8M

EPS$0.22

Market Cap$8.6B

Price Performance

Historical data including institutional events

Loading price data...

Company Profile

Christopher Anzalone

CEO & Executive Director

Arrowhead Pharmaceuticals, Inc. is a publicly traded biopharmaceutical company based in Pasadena, California. Arrowhead's products in development act through RNA interference (RNAi) mechanisms of action. The company focuses on treatments for hepatitis B, liver disease associated with alpha 1-antitrypsin deficiency and cardiovascular disease.

Founded: 2004
Employees: 609
Headquarters: PASADENA, CA, United States
Website: arrowheadpharma.com

⚡

Core Efficiency

ROE?

5.42%

ROA?

1.92%

Op. Margin?

15.46%

📊

Profitability Ratios

Net Margin?

11.67%

Current Ratio?

3.38

Loading company sections...

ARROWHEAD PHARMACEUTICALS, INC.

Price Performance

Company Profile

Core Efficiency

Profitability Ratios

Core Efficiency

Profitability Ratios

Earnings Calendar

Data Freshness